BNP Paribas Financial Markets
ELEV

BNP Paribas Financial Markets’s Elevation Oncology ELEV Stock Holding History

BNP Paribas Financial Markets’s Portfolio ELEV Stock Details ELEV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,082
Closed -$1.87K – 5610
2025
Q2 		$1.87K Sell
5,082
-1,505
-23% -$502 ﹤0.01% 5067
2025
Q1 		$1.71K Sell
6,587
-336
-5% -$192 ﹤0.01% 5004
2024
Q4 		$3.9K Buy
+6,923
New +$4.09K ﹤0.01% 4957

Other funds holding ELEV

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

BNP Paribas Financial Markets's ELEV Position: Q3 2025 in Review

BNP Paribas Financial Markets sold out of Elevation Oncology (ELEV) in Q3 2025, closing a stake of 5,082 shares — an estimated $1.87K sold.

BNP Paribas Financial Markets first reported a position in ELEV in Q4 2024 and held it in 3 quarters. The position peaked at $3.9K in Q4 2024. 1 fund tracked by Wall St. Rank holds ELEV as of Q3 2025.

  • BNP Paribas Financial Markets reported no remaining Elevation Oncology position as of Q3 2025 after selling out during the quarter.
  • BNP Paribas Financial Markets sold 5,082 Elevation Oncology shares in Q3 2025, an estimated $1.87K.
  • BNP Paribas Financial Markets first reported a position in Elevation Oncology in Q4 2024 and held it in 3 quarters.
  • BNP Paribas Financial Markets's Elevation Oncology position peaked at $3.9K in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Elevation Oncology as of Q3 2025.

Based on BNP Paribas Financial Markets's 13F filing for Q3 2025, filed 13 Nov 2025.